Today's Date: May 22, 2022
Four recipients of the 2022 Awards of Excellence in Nursing announced from Indigenous Services Canada   •   Sallie Mae’s Latest Corporate Social Responsibility Report Highlights Commitment to Customers, Communities, Employees, an   •   Checkmarx' Ana Lucia Amaral Honored as a CRN 2022 Woman of the Channel   •   Albertsons Companies, in cooperation with Smithfield Packaged Meats Corp., voluntarily recalls select ReadyMeals and deli-prepar   •   Equitable Bank Releases Inaugural ESG Performance Report   •   Belgard Canada Celebrates Canada Day With a Backyard Giveaway   •   Tracey Hayes from MicroAge Named on CRN's 2022 Women of the Channel Power 70 Solution Providers List   •   Steve and Marjorie Harvey Establish the Legacy Ranch in Upson County, Georgia - Building on The Rock Ranch founded by the Cathy   •   TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA) for ANNOVE   •   Merz Aesthetics Partners With North Carolina Courage of the National Women's Soccer League to Fuel Confidence on and off the fie   •   Eastern Bank Welcomes New Members To Its Board of Advisors and Board of Ambassadors   •   Igloo Releases New Playmate Coolers Inspired by Legendary Rapper The Notorious B.I.G.   •   Tia Extends “Whole Woman, Whole Life” Care Model With Fertility Services   •   Global Surrogacy Services Announces Outreach to Potential Gestational Surrogates in Three Southwestern States   •   Jeunesse Garners 8 Gold Stevies in 2022 American Business Awards   •   Closing the Health Disparity Gap for Black Women   •   RNR Tire Express Surprises Tampa-Area Woman with New Car in Mother's Day Giveaway   •   Mrs. Flowers Takes the Helm at Comfort Home Care, Rockville, MD   •   Five Bluum Standouts Honored on CRN 2022 Women of the Channel List   •   NCCI Golf Event Generates $25,000 for Kids' Chance of America Scholarships
Bookmark and Share

Good news to patients with corneal blindness: MIOK Keratoprosthesis, the World's First Artificial Cornea of 100% Non-biological

Good news to patients with corneal blindness: MIOK Keratoprosthesis, the World's First Artificial Cornea of 100% Non-biological Materials has been approved for listing in China.

PR Newswire

BEIJING, Jan. 18, 2022 /PRNewswire/ -- On December 7, 2021, MIOK Keratoprosthesis was approved for listing by NMPA, the Chinese agency for regulating drugs and medical devices. MIOK Keratoprosthesis is the world's first ever approved artificial cornea that requires no co-implantation of donor corneas, and is of great significance across the 60 million patients with corneal blindness worldwide, as MIOK Keratoprosthesis makes it no longer impossible to restore sight to patients with corneal blindness, and ease the burden on their families.

Microkpro Medical

Corneal transplantation is one of the key means to restore sight to patients with corneal blindness. However, there is a high risk for corneal grafting failures and server postoperative complications usually due to the complex immunologic responses to incompatibility in a transplanted organ. Other artificial corneas requiring co-implantation of donor corneas can not avoid such risks either. So MIOK Keratoprosthesis, an artificial cornea of 100% of non-biological materials and requiring no co-implantation of donor corneas, is an ideal option for treating patients with corneal blindness. 

MIOK Keratoprosthesis is mainly made of clear PMMA plastic with excellent  optical properties and tissue tolerance, and it is intended to restore sight to patients with corneal blindness by providing a transparent optical pathway through an opacified cornea in the treated eye.

With special design and processing, MIOK Keratoprosthesis delivers excellent performance in terms of transparency, light transmission and durability, in addition to high biocompatibility and ease of use for surgical operations, which make it quick integrated with surrounding tissues. With comparison with conventional corneal transplantation and other artificial corneas, MIOK Keratoprosthesis requires no co-implantation of donor cornea, which addresses the lack of donor corneas worldwide and effectively reduces the risk of severe postoperative complications and immune rejection responses. Furthermore, MIOK Keratoprosthesis is indicated to patients with corneal blindness, in cases where a corneal transplantation has failed or runs a high risk for failure, especially to patients with corneal graft failures, corneal scarring/vascularization, chemical/thermal burns, autoimmune diseases (Stevens-Johnson syndrome, pemphigoid, etc.), symblepharon, and severe dry eyes, etc. As a result, it is an effective treatment to patients with corneal blindness caused by a wide range of corneal injuries.

MIOK Keratoprosthesis, the world’s first ever approved artificial cornea that requires no co-implantation of donor corneas.

About Microkpro Medical

Beijing Microkpro Medical Instrument Co., Ltd. (Microkpro Medical), founded in 1997, is a company that is focused on artificial vision and committed to restoring vision to the blind through high-tech means. With a long-term unremitting efforts of its excellent R&D team, Microkpro Medical has launched a proprietary artificial cornea: MIOK Keratoprosthesis,  and completed its registration NMPA on December 7, 2021. NMPA is the Chinese agency for regulating drugs and medical devices.

And Microkpro Medical has a GMP compliant facility in Daxing Biological Pharmaceutical Industry Base, Beijing, with an annual production capacity of 100,000 Keratoprosthesis in ISO 7/Class 10,000 cleanrooms.

Reference

  1. Announcement from National Medical Products Administration(NMPA) of China. https://www.nmpa.gov.cn/directory/web/nmpa/yaowen/ypjgyw/20211207172819157.html (First sentence of the first paragraph, Second sentence)
  2. Official weibo of the Australian Embassy in China.

    https://weibo.com/1918101143/JdrWO1Vwp  (First sentence of the first paragraph)
  3. Official website of Massachusetts Eye and Ear Center.

    https://masseyeandear.org/medical-professionals/keratoprosthesis  (Second paragraph, third sentence)
  4. Technical Review Report from Center for Medical Device valuation f NMPA

    https://www.cmde.org.cn/directory/web/WS01/images/yMu5pL3HxKSjqENRWjIwMDA4NzijqS5wZGY=.pdf (Third paragraph, fourth paragraph, third sentence)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/good-news-to-patients-with-corneal-blindness-miok-keratoprosthesis-the-worlds-first-artificial-cornea-of-100-non-biological-materials-has-been-approved-for-listing-in-china-301463469.html

SOURCE Microkpro Medical



Back to top
| Back to home page
Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News